Evolent Health, Inc: shareholders and insiders

EVHNYSEHealthcare · Services-Management Services

Price

$3.93

November 18, 2026Market cap $439M

What Ploutos Investor adds for Evolent Health

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 10 fiscal years, from 2016
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 19, 2025 to Aug 28, 2026, from their own Form 4 filings.

14 Form 4s

Bought on the market

–

nobody

Sold on the market

$329.5K

1 person

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan100%
  • The rest0%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $329.5K by 1 person

  • 2025: no buys, no sales
  • 2026: no buys, sold $329.5K by 1 person
  • Aug 26, 2026Daniel Joseph McCarthyPRESIDENT
    Kind10b5-1
  • Jul 1, 2026Seth BlackleyChief Executive Officer
    Kind
  • Jul 1, 2026Seth BlackleyChief Executive Officer
    Kind
  • Jul 1, 2026Jonathan WeinbergGeneral Counsel
    Kind
  • Jul 1, 2026Jonathan WeinbergGeneral Counsel
    Kind
  • Jul 1, 2026Daniel Joseph McCarthyPRESIDENT
    Kind
  • Jul 1, 2026Daniel Joseph McCarthyPRESIDENT
    Kind
  • Jul 1, 2026Aammaad ShamsChief Accounting Officer
    Kind
  • Jun 4, 2026Toyin AjayiDirector
    Kind
  • Jun 4, 2026Russell Monroe GlassDirector
    Kind
  • Jun 4, 2026Peter J GruaDirector
    Kind
  • Jun 4, 2026Shawn M GuertinDirector
    Kind
  • Jun 4, 2026Richard M JelinekDirector
    Kind
  • Jun 4, 2026Kim KeckDirector
    Kind
  • Jun 4, 2026Jill D. SmithDirector
    Kind
  • Jun 4, 2026Brendan B SpringstubbDirector
    Kind
  • Jun 4, 2026Craig A. BarbaroshDirector
    Kind

From the Form 4s insiders file with the SEC within two business days of each trade.

Insiders and their shares

Every buy and sale by EVH's officers and directors from 2015 up to November 18, 2025, 11 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

3 Holders over 5%Sep 8, 2026 Latest filing
  • Cadian Capital Management, LPwith 2 more personsClass A Common Stock, par value $0.01 per share
    Share of class9.30%
  • BlackRock Portfolio Management LLCClass A Stock
    Share of class5.50%
  • Rubicon Fund II LPwith 5 more personsClass A Common Stock
    Share of class5.21%
Fell to 5% or less (7)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • Morgan Stanley2.70%Sep 8, 202613G/A
  • The Vanguard Group0.00%Mar 26, 202613G/A
  • Eventide Asset Management, LLC0.00%Feb 13, 202613G/A
  • FMR0.70%Feb 5, 202613G/A
  • Durable Capital Partners LP0.00%Nov 14, 202513G/A
  • Wellington Management Group LLP0.40%Jul 7, 202513G/A
  • RA Capital Management, L.P.3.10%Feb 14, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • D.E. Shaw
    In the quarter-34%
  • Point72 (Cohen)
    In the quarter
  • Citadel Advisors (Griffin)
    In the quarter+28%
  • Millennium Mgmt (Englander)
    In the quarter+124%
  • AQR Capital
    In the quarter+68%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 10.7% of its shares outstanding were held short, -7.8% since the report before.

Shares held short
11.90M
10.7%
Since the report before12.91M on Sep 30, 2026
-7.8%
5.6
2.12M
More days to cover thanof 4,578 US-listed companies with enough volume
67%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 8.22M
  • Nov 15, 2023: Shares held short 8.26M
  • Nov 30, 2023: Shares held short 7.83M
  • Dec 15, 2023: Shares held short 11.12M
  • Dec 29, 2023: Shares held short 10.69M
  • Jan 12, 2024: Shares held short 10.79M
  • Jan 31, 2024: Shares held short 11.19M
  • Feb 15, 2024: Shares held short 11.32M
  • Feb 29, 2024: Shares held short 11.24M
  • Mar 15, 2024: Shares held short 10.81M
  • Mar 28, 2024: Shares held short 10.61M
  • Apr 15, 2024: Shares held short 11.38M
  • Apr 30, 2024: Shares held short 11.25M
  • May 15, 2024: Shares held short 11.19M
  • May 31, 2024: Shares held short 11.54M
  • Jun 14, 2024: Shares held short 12.38M
  • Jun 28, 2024: Shares held short 12.53M
  • Jul 15, 2024: Shares held short 13.89M
  • Jul 31, 2024: Shares held short 14.33M
  • Aug 15, 2024: Shares held short 15.87M
  • Aug 30, 2024: Shares held short 14.61M
  • Sep 13, 2024: Shares held short 14.04M
  • Sep 30, 2024: Shares held short 12.53M
  • Oct 15, 2024: Shares held short 10.90M
  • Oct 31, 2024: Shares held short 12.49M
  • Nov 15, 2024: Shares held short 10.82M
  • Nov 29, 2024: Shares held short 10.51M
  • Dec 13, 2024: Shares held short 9.76M
  • Dec 31, 2024: Shares held short 10.19M
  • Jan 15, 2025: Shares held short 11.29M
  • Jan 31, 2025: Shares held short 11.16M
  • Feb 14, 2025: Shares held short 12.33M
  • Feb 28, 2025: Shares held short 14.20M
  • Mar 14, 2025: Shares held short 13.90M
  • Mar 31, 2025: Shares held short 15.89M
  • Apr 15, 2025: Shares held short 16.09M
  • Apr 30, 2025: Shares held short 16.75M
  • May 15, 2025: Shares held short 16.72M
  • May 30, 2025: Shares held short 17.46M
  • Jun 13, 2025: Shares held short 15.23M
  • Jun 30, 2025: Shares held short 16.49M
  • Jul 15, 2025: Shares held short 17.55M
  • Jul 31, 2025: Shares held short 18.83M
  • Aug 15, 2025: Shares held short 20.29M
  • Aug 29, 2025: Shares held short 22.61M
  • Sep 15, 2025: Shares held short 23.10M
  • Sep 30, 2025: Shares held short 18.81M
  • Oct 15, 2025: Shares held short 17.62M
  • Oct 31, 2025: Shares held short 17.06M
  • Nov 14, 2025: Shares held short 18.76M
  • Nov 28, 2025: Shares held short 18.15M
  • Dec 15, 2025: Shares held short 19.54M
  • Dec 31, 2025: Shares held short 19.63M
  • Jan 15, 2026: Shares held short 19.13M
  • Jan 30, 2026: Shares held short 19.20M
  • Feb 13, 2026: Shares held short 20.21M
  • Feb 27, 2026: Shares held short 18.33M
  • Mar 13, 2026: Shares held short 18.15M
  • Mar 31, 2026: Shares held short 15.95M
  • Apr 15, 2026: Shares held short 16.20M
  • Apr 30, 2026: Shares held short 15.39M
  • May 15, 2026: Shares held short 14.94M
  • May 29, 2026: Shares held short 14.79M
  • Jun 15, 2026: Shares held short 14.58M
  • Jun 30, 2026: Shares held short 15.83M
  • Jul 15, 2026: Shares held short 14.69M
  • Jul 31, 2026: Shares held short 15.81M
  • Aug 14, 2026: Shares held short 15.77M
  • Aug 31, 2026: Shares held short 15.47M
  • Sep 15, 2026: Shares held short 14.07M
  • Sep 30, 2026: Shares held short 12.91M
  • Oct 15, 2026: Shares held short 11.90M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading52.7% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 52.7% of the shares in the reported trades were short sales, against 51.4% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
52.7%
The 14 beforeOct 12, 2026 – Oct 29, 2026
51.4%
Change
+1.3 pts
Short sales a dayon average, of 497.2K shares
262.1K
More than atof 3,656 US-listed companies, same days
58%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 49.8%
  • Oct 13, 2026: Short sales 46.5%
  • Oct 14, 2026: Short sales 53.4%
  • Oct 15, 2026: Short sales 54.7%
  • Oct 16, 2026: Short sales 58.3%
  • Oct 19, 2026: Short sales 59.4%
  • Oct 20, 2026: Short sales 59.6%
  • Oct 21, 2026: Short sales 44.2%
  • Oct 22, 2026: Short sales 53.1%
  • Oct 23, 2026: Short sales 45.2%
  • Oct 26, 2026: Short sales 38.1%
  • Oct 27, 2026: Short sales 43.4%
  • Oct 28, 2026: Short sales 54.8%
  • Oct 29, 2026: Short sales 56.8%
  • Oct 30, 2026: Short sales 49.2%
  • Nov 2, 2026: Short sales 53.1%
  • Nov 3, 2026: Short sales 36.5%
  • Nov 4, 2026: Short sales 45.3%
  • Nov 5, 2026: Short sales 48.4%
  • Nov 6, 2026: Short sales 40.6%
  • Nov 9, 2026: Short sales 52.5%
  • Nov 10, 2026: Short sales 48.4%
  • Nov 11, 2026: Short sales 46.6%
  • Nov 12, 2026: Short sales 45.1%
  • Nov 13, 2026: Short sales 48%
  • Nov 16, 2026: Short sales 49.6%
  • Nov 17, 2026: Short sales 52.2%
  • Nov 18, 2026: Short sales 75.6%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

3.12M Insiders' shares2.80% Of the company
  • Seth BlackleyChief Executive Officer
    Directly1.27M
  • Daniel Joseph McCarthyPRESIDENT
    Directly655.1K
  • Jonathan WeinbergGeneral Counsel
    Directly284.9K
  • Peter J GruaDirector
    Directly123.7K
  • Richard M JelinekDirector
    Directly107.5K
  • Kim KeckDirector
    Directly102.6K
  • Brendan B SpringstubbDirector
    Directly99.9K
  • Aammaad ShamsChief Accounting Officer
    Directly95.6K
  • Craig A. BarbaroshDirector
    Directly95.0K
  • Russell Monroe GlassDirector
    Directly83.4K
  • Toyin AjayiDirector
    Directly75.2K
  • Jill D. SmithDirector
    Directly64.2K
  • Shawn M GuertinDirector
    Directly63.1K

A lower bound: it counts only the 13 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

15 ETFs holding it0.09% The largest weight (IHF)
  • IHFiShares U.S. Healthcare Providers ETF
    Weight in the fund0.09%
  • FNDASchwab Fundamental U.S. Small Company ETF
    Weight in the fund0.05%
  • IWNiShares Russell 2000 Value ETF
    Weight in the fund0.03%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.02%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.02%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.01%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.01%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.01%
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.01%
  • DFSVDimensional US Small Cap Value ETF
    Weight in the fund0.00%

15 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

199 Managers, Q2 2026$608M Value of their positions
  • Q3 2025: Managers 241
  • Q4 2025: Managers 215
  • Q1 2026: Managers 195
  • Q2 2026: Managers 199

Institutional investors by quarter

The fund managers holding EVH, quarter by quarter, from Q2 2015 to Q2 2025, 41 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 199 managers held 112M shares, worth $608M. During the quarter 37 opened a position, 33 closed one, 66 added and 63 trimmed.

The largest holders, Q2 2026

  • BlackRock
    In the quarter+36%
  • Cadian Capital Management
    In the quarter
  • Morgan Stanley
    In the quarter-1.2%
  • UBS Group
    In the quarter-23%
  • Rubicon Founders
    In the quarter
  • Engaged Capital
    In the quarter
  • D.E. Shaw
    In the quarter-6.0%
  • Vanguard Capital Management
    In the quarter-1.6%
  • Marshall Wace
    In the quarter+335%
  • Nuveen
    In the quarter×11.8

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Evolent Health's filings show?

Who buys and sells is one part of Evolent Health's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about EVH's shareholders

Didn't find what you were looking for?

Ask us
Have EVH's insiders bought or sold?

From Jun 8, 2026 to Aug 28, 2026 Evolent Health's insiders bought 0 and sold $329.5K of shares on the market. 100% of the sales were under set 10b5-1 plans.

Which well-known managers hold EVH?

5 of the managers we track held the shares on Sep 30, 2026. The largest position was D.E. Shaw's, worth $12M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.